Henry Schein is a medical distribution business based in the US. Henry Schein shares (HSIC) are listed on the NASDAQ and all prices are listed in US Dollars. Henry Schein employs 25,000 staff and has a trailing 12-month revenue of around $12.5 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $70.29 |
|---|---|
| 52-week range | $60.01 - $82.63 |
| 50-day moving average | $68.68 |
| 200-day moving average | $71.38 |
| Wall St. target price | $77.40 |
| PE ratio | 23.6835 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $2.97 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $70.29 from 2024-07-24
| 1 week (2024-07-18) | -0.54% |
|---|---|
| 1 month (2024-06-25) | 6.34% |
| 3 months (2024-04-25) | -3.47% |
| 6 months (2024-01-25) | -5.06% |
| 1 year (2023-07-25) | -12.29% |
|---|---|
| 2 years (2022-07-25) | -9.21% |
| 3 years (2021-07-23) | 77.36 |
| 5 years (2019-07-25) | 4.30% |
Valuing Henry Schein stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Henry Schein's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Henry Schein's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Henry Schein shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Henry Schein's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6515. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Henry Schein's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Henry Schein's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $934 million.
The EBITDA is a measure of a Henry Schein's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $12.5 billion |
|---|---|
| Operating margin TTM | 5.74% |
| Gross profit TTM | $3.8 billion |
| Return on assets TTM | 4.44% |
| Return on equity TTM | 8.34% |
| Profit margin | 3.12% |
| Book value | $28.02 |
| Market Capitalization | $9 billion |
TTM: trailing 12 months
We're not expecting Henry Schein to pay a dividend over the next 12 months.
Henry Schein's shares were split on a 1275:1000 basis on 7 February 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1275 shares. This wouldn't directly have changed the overall worth of your Henry Schein shares – just the quantity. However, indirectly, the new 21.6% lower share price could have impacted the market appetite for Henry Schein shares which in turn could have impacted Henry Schein's share price.
Over the last 12 months, Henry Schein's shares have ranged in value from as little as $60.01 up to $82.63. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Henry Schein's is 0.874. This would suggest that Henry Schein's shares are less volatile than average (for this exchange).
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.